Elaina Cajulis
About
In The Last Decade
Elaina Cajulis
23 papers receiving 824 citations
Peers
Comparison fields: 5 of 75
- Molecular Biology 432
- Oncology 301
- Pulmonary and Respiratory Medicine 224
- Endocrinology, Diabetes and Metabolism 135
- Cancer Research 126
Countries citing papers authored by Elaina Cajulis
This map shows the geographic impact of Elaina Cajulis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elaina Cajulis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elaina Cajulis more than expected).
Fields of papers citing papers by Elaina Cajulis
This network shows the impact of papers produced by Elaina Cajulis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elaina Cajulis. The network helps show where Elaina Cajulis may publish in the future.
Co-authorship network of co-authors of Elaina Cajulis
This figure shows the co-authorship network connecting the top 25 collaborators of Elaina Cajulis. A scholar is included among the top collaborators of Elaina Cajulis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elaina Cajulis. Elaina Cajulis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 33 | |
| 2 | 41 | |
| 3 | 19 | |
| 4 | 28 | |
| 5 | 65 | |
| 6 | 113 | |
| 7 | 197 | |
| 8 | Inhibition of endocrine IGF-1 signaling in normal murine tissues and human tumor xenografts with AMG 479, a fully human anti IGF-1R monoclonal antibody | 4 |
| 9 | AMG 479, a fully human anti IGF-1 receptor monoclonal antibody, is efficacious against Ewing’s sarcoma and osteosarcoma xenografts | 6 |
| 10 | 1 | |
| 11 | 45 | |
| 12 | 15 | |
| 13 | 170 | |
| 14 | 10 | |
| 15 | Correlation of the in vitro and in vivo immunosuppressive activity of brequinar sodium. | 2 |
| 16 | Individual and species differences in the in vitro sensitivity to brequinar sodium. | 1 |
| 17 | Use of brequinar sodium for preventing cardiac allograft rejection in primates. | 4 |
| 18 | Brequinar sodium: monitoring immunosuppressive activity. | 4 |
| 19 | 10 | |
| 20 | FK 506 inhibits the development of transplant arteriosclerosis. | 10 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.